Roberto Formisano Discusses the Complexities of Technology Transfer in Cell and Gene Therapy Industry

Current developments in technology transfer to a Contract Development and Manufacturing Organization (CDMO)

Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, discusses the challenges associated with technology transfer in a video interview with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March. In the interview, Roberto provides insights on the nuances of technology transfer from development to GMP manufacturing and from a customer to a contract development and manufacturing organization (CDMO).

One of the key challenges that Roberto discusses is the critical timelines that are integral to the process of technology transfer. Balancing the number of batches that need to be manufactured to ensure sufficient quality data while adhering to these timelines poses a significant challenge in the industry.

Roberto also shares his predictions on technology and manufacturing trends that are expected to shape the cell and gene therapy industry by 2024. His insights provide valuable perspectives on the future direction of the industry.

The interview sheds light on the complexities of technology transfer and offers valuable insights into the industry’s challenges and opportunities.

Leave a Reply